Tadalafil
T2 Trial
Approved small_molecule terminated
Quick answer
Tadalafil for Pulmonary Arterial Hypertension is a Approved program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Pulmonary Arterial Hypertension
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated